Extracellular matrix biomimetics for pancreatic tissue engineering

Isolated islet transplantation offers a safer and less invasive alternative to whole pancreas transplantation for patients with complicated type 1 diabetes mellitus. However, the procedure faces significant challenges, including the loss of vascularization, innervation, and extracellular matrix (ECM) support. Additionally, factors such as hypoxia, oxidative stress, inflammatory responses, and the cytotoxic effects of immunosuppressive therapy compromise islet viability significantly and limit long-term graft function. Tissue engineering and regenerative medicine strategies aim to address these challenges. A central objective is the development of biocompatible, biomimetic ECM scaffolds (frameworks, carriers, or matrices) that can provide both mechanical support and a suitable microenvironment for islet cells in vitro and in vivo . This review aims to systematize current data on the use of biomimetic ECMs in the creation of stable, tissue-engineered pancreatic constructs.

Authors

Institutions

Publication Details

Journal
Russian Journal of Transplantology and Artificial Organs
Published
2025-09-03
DOI
https://doi.org/10.15825/1995-1191-2025-3-146-159
Citations
1
Primary Topic
Pancreatic function and diabetes
Type
article
Field-Weighted Citation Impact
2.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Extracellular matrix biomimetics for pancreatic tissue engineering

N. V. Baranova, Yu. B. Basok, V. I. Sevastianov, А. С. Пономарева
1 citations
Russian Journal of Transplantology and Artificial Organs
Pancreatic function and diabetes
2.01
article

Extracellular matrix biomimetics for pancreatic tissue engineering

N. V. Baranova, Yu. B. Basok, V. I. Sevastianov, А. С. Пономарева
article en
1 citations

Abstract

Isolated islet transplantation offers a safer and less invasive alternative to whole pancreas transplantation for patients with complicated type 1 diabetes mellitus. However, the procedure faces significant challenges, including the loss of vascularization, innervation, and extracellular matrix (ECM) support. Additionally, factors such as hypoxia, oxidative stress, inflammatory responses, and the cytotoxic effects of immunosuppressive therapy compromise islet viability significantly and limit long-term graft function. Tissue engineering and regenerative medicine strategies aim to address these challenges. A central objective is the development of biocompatible, biomimetic ECM scaffolds (frameworks, carriers, or matrices) that can provide both mechanical support and a suitable microenvironment for islet cells in vitro and in vivo . This review aims to systematize current data on the use of biomimetic ECMs in the creation of stable, tissue-engineered pancreatic constructs.

Russian Journal of Transplantology and Artificial OrgansVol. 27(3)
V.I.Shumakov Federal Research Center of Transplantology and Artificial Organs (RU)
Openalex Percentile: Top 12%
Pancreatic function and diabetes
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.